AgeX Therapeutics, Inc.·4

Mar 13, 6:09 PM ET

MALIK NAFEES NASEER 4

4 · AgeX Therapeutics, Inc. · Filed Mar 13, 2019

Insider Transaction Report

Form 4
Period: 2019-03-11
MALIK NAFEES NASEER
Chief Operating Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2019-03-11+70,00070,000 total
    Exercise: $4.28Exp: 2029-03-10Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]One quarter shall vest on March 11, 2020 and the remaining shall vest monthly over 36 months, based upon continuous service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION